DOCSLIB.ORG

Dermatology Practical & Conceptual

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dermatology Practical & Conceptual DERMATOLOGY PRACTICAL & CONCEPTUAL www.derm101.com Abstracts from the 4th World Congress of the International Dermoscopy Society, April 16-18, 2015, Vienna, Austria Citation: Abstracts from the 4th World Congress of the International Dermoscopy Society, April 16-18, 2015, Vienna, Austria. Dermatol Pract Concept 2015;5(2):28. http://dx.doi.org/10.5826/dpc.0502a28 ORAL PRESENTATIONS carcinoma and basal cell carcinoma), as well as infectious and genetic disease (storage diseases), could be evocated. The detection of parasites (Demodex folliculorum) on eye- FREE COMMUNICATIONS: lids was possible. Confocal images correlated well with con- CONFOCAL AND OCT ventional histopathology. The fluorescence examination of corneal squamous cell carcinoma by VivaScope 1500 was FC1-1 characterized by extravasation of fluorescein after intrave- nous injection. IN VIVO CONFOCAL MICROSCOPES DEDICATED TO THE SKIN FOR THE EXPLORATION OF THE Conclusions: Confocal microscopes dedicated to the skin of- fer new perspectives for the diagnosis, optimization of treat- OCULAR SURFACE: A NEW PERSPECTIVE FOR ments, and follow-up of the ocular diseases. They will allow DERMATOLOGISTS dermatologists to examine conjunctival and eyelid tumors, as it is for skin or genital mucosa. In addition, thanks to *1 1 1 Elisa Cinotti , Jean-Luc Perrot , Bruno Labeille , some adaptations of the dermatological device VivaScope® Gilles Thuret2, Damien Grivet2, Philippe Gain2, 1500, it is possible for the first time to perform a fluorsecnte Frédéric Cambazard1 examination of the ocular and peri-ocular tissue, opening a new era in the clinical imaging of the ocular surface. A new 1 2 Dermatology, Opthalmology, University Hospital of Saint-Etienne, semiology remains to be learned. Saint-Etienne, France Background: In vivo confocal microscopy is an imaging FC1-2 technique that has been applied to the study of the ocular surface. However, confocal microscopes dedicated to eye PINK PLAQUES ON THE LEGS. THE ROLE OF examination are routinely adopted only in ophthalmology REFLECTANCE CONFOCAL MICROSCOPY reference centres and do not allow an examination of peri- ocular tissue, nor a fluorescence examination. Ignacio Gómez Martín*1, Sara Moreno Fernández1, Methods: We applied for the first time the two in vivo confo- Ramon M Pujol Vallverdú1, Sonia Segura Tigell1 cal microscopes commonly used in dermatology (VivaScope ® 1500 and 3000, CALIBER, distributed in Europe by Mavig 1Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain GmbH, Munich, Germany) to observe the cornea, the bulbar Introduction and Objectives: Pink plaques on the legs in el- and tarsal conjunctiva, the eyelid margin, the lacrimal punc- derly often represent a challenge for clinicians because of the tum and the palpebral skin of healthy volunteers. Tumoral, broad differential diagnosis. There is a great diagnostic vari- inflammatory and infectious diseases of the ocular mucosa ety of either tumoral and inflammatory diseases. The diagno- and periocular skin from more than 200 patients were ob- sis is complicated by the paucity of clinical and dermoscopic served under the same microscopes. Both microscopes have morphological clues and the existence of varying degrees of a reflectance mode. VivaScope® 1500 allows an additional xerosis, sun damage and venous stasis dermatitis. In addi- fluorescent examination and its placement on the ocular sur- tion, dermoscopic algorithms routinely used for pigmented face was made possible by the creation of a special interface lesions are not very helpful in the diagnosis of pink plaques. between the microscope and the ocular apparatus. Reflectance confocal microscopy (RCM) is a useful non-in- Results: Thanks to its compact and flexible configuration, vasive complementary tool in the diagnosis of malignancy. the handheld camera VivaScope® 3000 allowed to access The aim of our study was to describe the utility of RCM in more easily to the ocular and periocular tissues. Diagnosis pink plaques on the legs in photodamaged skin and to cor- of benign and malignant tumors (melanoma, squamous cell relate the findings with histopathology. Supplement | Dermatol Pract Concept 2015;5(2):28 137 Materials and Methods: Prospective study of 47 pink plaques evaluated at 4 different moments up to the end of photo- on the legs from 36 patients (10 males, 26 females, mean therapy. age: 72 years (44-91)). A 4mm punch biopsy was performed Results: Dermoscopy showed regression phenomena (with in all cases. Clinical, dermoscopic and RCM images were loss of structures such as network and dots/globules) and stored and blindly evaluated for clinical, dermoscopic and inflammatory features (such as dotted and fine telangiecta- RCM diagnosis. Analysis of dermoscopic and RCM criteria sic vessels and diffuse erythema). On RCM, predominantly described in the literature and subsequent correlation with at the middle and end of protocol, the appearance of large histopathology were also performed. dendritic cells within epidermis was observed, like real mela- Results: 13 benign lesions (8 stasis dermatitis, 1 lichen pla- noma simulators. Immunohistopathology confirmed the nus, 1 viral wart, 1 scar, 1 neurofibroma, 1 lichen planus-like presence of activated melanocytes that could correspond to keratosis) and 34 malignant neoplasms (20 basal cell car- the images seen on RCM. The presence of regression, mela- cinoma (BCC), 14 Bowen’s disease) were analysed. A cor- nophages and perivascular lymphocytic inflammatory infil- rect clinical diagnosis was established in only 38% of cases trate also corroborates the dermoscopy findings. Regarding (18/47). Dermoscopy following clinical assessment achieved the sunscreen protection role, we could verify nbUVB effects on both unprotected and protected halves, but more obvi- 49% (23/47) of correct diagnosis, whereas RCM evaluation ously demonstrated on the unprotected halves. after clinical and dermoscopic evaluation rendered a correct diagnosis in 72% of cases (35/47). Conclusions: Benign melanocytic nevi can show features re- sembling melanoma on RCM images when they are evalu- Conclusions: Dermoscopic criteria of pink plaques on the legs ated after repeated nbUVB sub-erythematogenic doses. This are frequently not enough to set a proper diagnosis, due to means that we have to be aware of RCM pitfalls, especially lack of specific features. RCM may improve our diagnostic in the context of recent UVR exposure, since these lesions accuracy as a secondary evaluation after dermoscopy. can simulate melanomas. FC1-3 FC1-4 DOES PHOTOTHERAPY INDUCE MELANOMA IN VIVO REFLECTANCE CONFOCAL MICROSCOPY SIMULATORS? ROLE OF CONFOCAL MICROSCOPY (RCM) OF MELANOTIC MACULES—KEY FEATURES IN THE EVALUATION OF NEVI UNDERGOING NBUVB AND IMPACT OF RCM ON NON-INVASIVE IRRADIATION DIAGNOSIS AND TREATMENT *1 1 Caroline M. Takigami , Mauricio Gamboa , Marion Christine Prodinger*1, Martin Laimer1, Edith Arzberger2, 1 1, 2 3 Chavez-Bourgeois , Paula Aguilera , Llucia Alos , Clara Kirchner1, Rainer Hofmann-Wellenhof2, 2, 4 2, 4 1, 4 Josep Malvehy , Susana Puig , Cristina Carrera Verena Ahlgrimm-Siess1 1 2 Dermatology Department, Hospital Clínic de Barcelona, CIBER 1Dermatology, Paracelsus Medical University of Salzburg, Salzburg, Enfermedades Raras, Instituto de Salud Carlos III, 3Pathology 2Dermatology, Medical University of Graz, Graz, Austria Department, Hospital Clínic de Barcelona, 4Melanoma Unit, University of Barcelona, Barcelona, Spain Background: The distinction of melanotic macules and mel- anoma is momentous but poses a major challenge in the Background: Previous studies (1) have shown that UVR can daily routine due to overlapping clinical and dermoscopic be responsible for inducing dynamic changes in nevi. Howev- features. Repeated biopsies and lifelong follow-up may be er, further characterization of these likely dynamic and tran- necessary to rule out malignancy. RCM can assist ascertain sient events are required. Reflectance Confocal Microscopy the diagnosis, by allowing visualization of the skin at nearly (RCM) is a non-invasive in vivo imaging technique which histological resolution. allows the evaluation over time of the same lesion obtaining Objectives: The validity and reproducibility of RCM criteria high sensitivity and specificity in cutaneous lesion diagnosis for melanotic macules of mucocutaneous junctions (MCJ) is (2). With this valuable tool, we could better recognize the tested in order to evaluate the diagnostic value of RCM for role of sunscreens in the prevention of these changes on nevi. these lesions. Further the impact of RCM on lowering the Objectives and Method: To make a comparative description excision rate of melanotic macules compared to clinical and of the same nevi with and without sunscreen application dermoscopic evaluation alone is investigated. over time, during narrow band UVB therapy, by means of Methods: A retrospective RCM image analysis of 39 pig- dermoscopy and RCM. Patients who were programmed to mented macules (31 melanotic macules, 2 banal nevi, 4 receive nbUVB phototherapy for their underlying dermato- atypical nevi, 2 in situ melanomas) on genital (23) and labial sis were included and submitted to the same irradiated nevi (16) MCJ was done by two groups of investigators blinded protocol designed by Carrera et al (1). The selected nevi were to diagnoses, novices vs. expert. Both groups had to opt for divided into two halves, one with and the other without sun- a differential diagnosis (melanotic macule or benign/atypi- screen before nbUVB sub-erythematogenic
Load more

Recommended publications
  • Hemangiosarcoma Philip J
    Ettinger & Feldman – Textbook of Veterinary Internal Medicine Client Information Sheet Hemangiosarcoma Philip J. Bergman What is hemangiosarcoma? Hemangiosarcoma (HSA; angiosarcoma or malignant hemangioendothelioma) is an extremely aggressive tumor of blood vessel origin. Because blood vessels are present throughout the body, virtually any site in the body can have HSA. HSA occurs most frequently in dogs (approximately 2% of all tumors) and the most common site is the spleen. However, additional common sites include the heart, liver, muscle, lung skin, bones, kidney, brain, abdomen, and oral cavity. In three large canine splenic disease studies encompassing approximately 2000 dogs, a “rule of two thirds” was found suggesting that approximately two thirds of dogs with a splenic mass have a cancer (therefore one third are not malignant) and two thirds of the malignant tumors of the spleen are HSA. HSA is a disease generally of older dogs and cats with an average onset of 9 to 10 years; however, there are reports of extremely young dogs and cats with this disease (5 to 6 months to a few years of age). German shepherd dogs are most commonly diagnosed with HSA; however, other large breed dogs such as golden retrievers and Labrador retrievers may also be overrepresented. In cats, the most common breed is the domestic shorthair. The cause of HSA in dogs and cats is presently unknown. Exposures to toxins such as chemicals, insecticides, and radiation have been reported in humans to be associated with HSA. Ultraviolet light exposure from the sun may be a potential cause of HSA in dogs, as HSAs of the skin are commonly seen in dogs with light hair and poor pigmentation (e.g., Salukis, Whippets, and white Bulldogs).
    [Show full text]
  • Tumors and Tumor-Like Lesions of Blood Vessels 16 F.Ramon
    16_DeSchepper_Tumors_and 15.09.2005 13:27 Uhr Seite 263 Chapter Tumors and Tumor-like Lesions of Blood Vessels 16 F.Ramon Contents 42]. There are two major classification schemes for vas- cular tumors. That of Enzinger et al. [12] relies on 16.1 Introduction . 263 pathological criteria and includes clinical and radiolog- 16.2 Definition and Classification . 264 ical features when appropriate. On the other hand, the 16.2.1 Benign Vascular Tumors . 264 classification of Mulliken and Glowacki [42] is based on 16.2.1.1 Classification of Mulliken . 264 endothelial growth characteristics and distinguishes 16.2.1.2 Classification of Enzinger . 264 16.2.1.3 WHO Classification . 265 hemangiomas from vascular malformations. The latter 16.2.2 Vascular Tumors of Borderline classification shows good correlation with the clinical or Intermediate Malignancy . 265 picture and imaging findings. 16.2.3 Malignant Vascular Tumors . 265 Hemangiomas are characterized by a phase of prolif- 16.2.4 Glomus Tumor . 266 eration and a stationary period, followed by involution. 16.2.5 Hemangiopericytoma . 266 Vascular malformations are no real tumors and can be 16.3 Incidence and Clinical Behavior . 266 divided into low- or high-flow lesions [65]. 16.3.1 Benign Vascular Tumors . 266 Cutaneous and subcutaneous lesions are usually 16.3.2 Angiomatous Syndromes . 267 easily diagnosed and present no significant diagnostic 16.3.3 Hemangioendothelioma . 267 problems. On the other hand, hemangiomas or vascular 16.3.4 Angiosarcomas . 268 16.3.5 Glomus Tumor . 268 malformations that arise in deep soft tissue must be dif- 16.3.6 Hemangiopericytoma .
    [Show full text]
  • Cutaneous Angiosarcoma: Report of Three Different and Typical Cases Admitted in a Unique Dermatology Clinic*
    CASE REPORT 235 s Cutaneous angiosarcoma: report of three different and typical cases admitted in a unique dermatology clinic* Aline Neves Freitas Cabral1 Rafael Henrique Rocha1 Ana Cristina Vervloet do Amaral1 Karina Bittencourt Medeiros2 Paulo Sérgio Emerich Nogueira1 Lucia Martins Diniz3 DOI: http://dx.doi.org/10.1590/abd1806-4841.20175326 Abstract: Angiosarcoma is a rare and aggressive tumor with high rates of metastasis and relapse. It shows a particular predi- lection for the skin and superficial soft tissues. We report three distinct and typical cases of angiosarcoma that were diagnosed in a single dermatology clinic over the course of less than a year: i) Angiosarcoma in lower limb affected by chronic lymph- edema, featuring Stewart-Treves syndrome; ii) a case of the most common type of angiosarcoma loated in the scalp and face of elderly man and; iii) a skin Angiosarcoma in previously irradiated breast. All lesions presented characteristic histopathological findings: irregular vascular proliferation that dissects the collagen bundles with atypical endothelial nuclei projection toward the lumen. Keywords: Hemangiosarcoma; Lymphangiosarcoma; Lymphedema; Non-Filarial Lymphedema; Sarcoma INTRODUCTION Angiosarcoma (AS) is a rare and aggressive neoplasm, that fibers, formed by endothelium with atypical nuclei, prominent to- originates from endothelial cells of lymphatic and blood vessels. It ac- ward the lumen; The tumoral lesion exhibited cohesive epithelioid counts for 5% of malignant skin tumors and less than 1% of all sarco- masses of atypical, large, rounded cells with acidophilic cytoplasm mas. It is notable for having a predilection for the skin and superficial and frequent mitotic figures. (Figure 2). Immunohistochemical anal- soft tissues.
    [Show full text]
  • Toxicological Profile for Glyphosate Were
    A f Toxicological Profile for Glyphosate August 2020 GLYPHOSATE II DISCLAIMER Use of trade names is for identification only and does not imply endorsement by the Agency for Toxic Substances and Disease Registry, the Public Health Service, or the U.S. Department of Health and Human Services. GLYPHOSATE III FOREWORD This toxicological profile is prepared in accordance with guidelines developed by the Agency for Toxic Substances and Disease Registry (ATSDR) and the Environmental Protection Agency (EPA). The original guidelines were published in the Federal Register on April 17, 1987. Each profile will be revised and republished as necessary. The ATSDR toxicological profile succinctly characterizes the toxicologic and adverse health effects information for these toxic substances described therein. Each peer-reviewed profile identifies and reviews the key literature that describes a substance's toxicologic properties. Other pertinent literature is also presented, but is described in less detail than the key studies. The profile is not intended to be an exhaustive document; however, more comprehensive sources of specialty information are referenced. The focus of the profiles is on health and toxicologic information; therefore, each toxicological profile begins with a relevance to public health discussion which would allow a public health professional to make a real-time determination of whether the presence of a particular substance in the environment poses a potential threat to human health. The adequacy of information to determine a substance's
    [Show full text]
  • 8.5 X12.5 Doublelines.P65
    Cambridge University Press 978-0-521-87409-0 - Modern Soft Tissue Pathology: Tumors and Non-Neoplastic Conditions Edited by Markku Miettinen Index More information Index abdominal ependymoma, 744 mucinous cystadenocarcinoma, 631 adult fibrosarcoma (AF), 364–365, 1026 abdominal extrauterine smooth muscle ovarian adenocarcinoma, 72, 79 adult granulosa cell tumor, 523–524 tumors, 79 pancreatic adenocarcinoma, 846 clinical features, 523 abdominal inflammatory myofibroblastic pulmonary adenocarcinoma, 51 genetics, 524 tumors, 297–298 renal adenocarcinoma, 67 pathology, 523–524 abdominal leiomyoma, 467, 477 serous cystadenocarcinoma, 631 adult rhabdomyoma, 548–549 abdominal leiomyosarcoma. See urinary bladder/urogenital tract clinical features, 548 gastrointestinal stromal tumor adenocarcinoma, 72, 401 differential diagnosis, 549 (GIST) uterine adenocarcinomas, 72 genetics, 549 abdominal perivascular epithelioid cell tumors adenofibroma, 523 pathology, 548–549 (PEComas), 542 adenoid cystic carcinoma, 1035 aggressive angiomyxoma (AAM), 514–518 abdominal wall desmoids, 244 adenomatoid tumor, 811–813 clinical features, 514–516 acquired elastotic hemangioma, 598 adenomatous polyposis coli (APC) gene, 143 differential diagnosis, 518 acquired tufted angioma, 590 adenosarcoma (mullerian¨ adenosarcoma), 523 genetics, 518 acral arteriovenous tumor, 583 adipocytic lesions (cytology), 1017–1022 pathology, 516 acral myxoinflammatory fibroblastic sarcoma atypical lipomatous tumor/well- aggressive digital papillary adenocarcinoma, (AMIFS), 365–370, 1026 differentiated
    [Show full text]
  • Laser Dermatology
    Laser Dermatology David J. Goldberg Editor Laser Dermatology Second Edition Editor David J. Goldberg, M.D. Division of New York & New Jersey Skin Laser & Surgery Specialists Hackensack , NY USA ISBN 978-3-642-32005-7 ISBN 978-3-642-32006-4 (eBook) DOI 10.1007/978-3-642-32006-4 Springer Heidelberg New York Dordrecht London Library of Congress Control Number: 2012954390 © Springer-Verlag Berlin Heidelberg 2013 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, speci fi cally the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on micro fi lms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied speci fi cally for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work. Duplication of this publication or parts thereof is permitted only under the provisions of the Copyright Law of the Publisher’s location, in its current version, and permission for use must always be obtained from Springer. Permissions for use may be obtained through RightsLink at the Copyright Clearance Center. Violations are liable to prosecution under the respective Copyright Law. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a speci fi c statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use.
    [Show full text]
  • Expert-Level Diagnosis of Nonpigmented Skin Cancer by Combined Convolutional Neural Networks
    Supplementary Online Content Tschandl P, Rosendahl C, Akay BN, et al. Expert-level diagnosis of nonpigmented skin cancer by combined convolutional neural networks. JAMA Dermatol. Published online November 28, 2018. doi:10.1001/jamadermatol.2018.4378 eFigure. Sensitivities (Blue) and Specificities (Orange) at Different Threshold Cutoffs (Green) of the Combined Classifier Evaluated on the Validation Set eAppendix. Neural Network Training eTable 1. Complete List of Diagnoses and Their Frequencies Within the Test-Set eTable 2. Education of Users According to Their Experience Group eTable 3. Percent of Correct Prediction of the Malignancy Status for Specific Diagnoses of a CNN Using Either Close-up or Dermatoscopic Images This supplementary material has been provided by the authors to give readers additional information about their work. © 2018 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/25/2021 eFigure. Sensitivities (Blue) and Specificities (Orange) at Different Threshold Cutoffs (Green) of the Combined Classifier Evaluated on the Validation Set A threshold cut at 0.2 (black) is found for a minimum of 51.3% specificity. © 2018 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/25/2021 eAppendix. Neural Network Training We compared multiple architecture and training hyperparameter combinations in a grid-search fashion, and used only the single best performing network for dermoscopic and close-up images, based on validation accuracy, for further analyses. We trained four different CNN architectures (InceptionResNetV2, InceptionV3, Xception, ResNet50) and used model definitions and ImageNet pretrained weights as available in the Tensorflow (version 1.3.0)/ Keras (version 2.0.8) frameworks.
    [Show full text]
  • Aesthetic Treatment Outcomes of Capillary Hemangioma, Venous
    International Journal of Environmental Research and Public Health Article Aesthetic Treatment Outcomes of Capillary Hemangioma, Venous Lake, and Venous Malformation of the Lip Using Different Surgical Procedures and Laser Wavelengths (Nd:YAG, Er,Cr:YSGG, CO2, and Diode 980 nm) Samir Nammour 1,* , Marwan El Mobadder 1 , Melanie Namour 1 , Amaury Namour 1, Josep Arnabat-Dominguez 2 , Kinga Grzech-Le´sniak 3 , Alain Vanheusden 1 and Paolo Vescovi 4 1 Department of Dental Science, Faculty of Medicine, University of Liege, 4000 Liege, Belgium; [email protected] (M.E.M.); [email protected] (M.N.); [email protected] (A.N.); [email protected] (A.V.) 2 School of Dentistry, University of Barcelona, 08907 Barcelona, Spain; [email protected] 3 Dental Surgery Department, Medical University of Wroclaw, 50-425 Wroclaw, Poland; [email protected] 4 Department of Medicine and Surgery, University of Parma, 43121 Parma, Italy; [email protected] * Correspondence: [email protected] Received: 20 October 2020; Accepted: 20 November 2020; Published: 22 November 2020 Abstract: Different approaches with different clinical outcomes have been found in treating capillary hemangioma (CH), venous lake (VL), or venous malformations (VM) of the lips. This retrospective study aims to assess scar quality, recurrence rate, and patient satisfaction after different surgeries with different laser wavelengths. A total of 143 patients with CH or VM were included. Nd:YAG laser was used for 47 patients, diode 980 nm laser was used for 32 patients (treatments by transmucosal photo-thermo-coagulation), Er,Cr:YSSG laser was used for 12 patients (treatments by excision), and CO2 laser was used for 52 patients (treatments by photo-vaporization).
    [Show full text]
  • Hepatic Angiosarcoma Masquerading As Hemangioma
    Hepatic Angiosarcoma Masquerading as Hemangioma: A CASO CLÍNICO Challenging Differential Diagnosis Angiosarcoma Hepático e Hemangioma: Um Diagnóstico Diferencial Desafiante Ana Rita GARCIA1, João RIBEIRO1, Helena GERVÁSIO1, Francisco Castro e SOUSA2,3 Acta Med Port 2017 Oct;30(10):750-753 ▪ https://doi.org/10.20344/amp.8593 ABSTRACT Hemangiomas are usually diagnosed based on ultrasound findings. The presence of symptoms, rapid growth or atipical imagiological findings should make us consider other diagnoses, including malignant tumors such as angiosarcomas. We describe the case of a previously healthy 46-year-old female without a history of exposure to carcinogens who presented with abdominal pain for two months. Diagnostic work-up revealed elevated gamma-glutamyl transferase and lactate dehydrogenase levels. Abdominal ultrasound described a large nodular lesion in the right lobe of the liver described as a hemangioma. One month later, a computed tomography-scan was made and revealed the same lesion, which had grown from 13.5 to 20 cm, maintaining typical imaging characteristics of a hemangioma. A right hepatectomy was performed and pathology revealed an angiosarcoma. After surgery, a positron emission tomography-com- puted tomography scan showed hepatic and bone metastasis. The patient started taxane-based chemotherapy and lumbar palliative radiotherapy, but died 10 months after surgery. This case shows how difficult it is to diagnose hepatic angiosarcoma relying only on imaging findings. Two abdominal computed tomography -scans were performed and none suggested this diagnosis. Angiosarcoma is a very aggressive tumour with an adverse prognosis. Surgery is the only curative treatment available. However, it is rarely feasible due to unresectable disease or distant metastasis.
    [Show full text]
  • Canine Hemangiosarcoma
    Canine Hemangiosarcoma What is hemangiosarcoma? Hemangiosarcoma is a generally aggressive malignant tumor that originates from the blood vessels in various parts of the body. It can occur in all dogs, but is most common in the large breeds. It often results in internal bleeding and secondary complications. What types of hemangiosarcoma affect dogs? Hemangiosarcoma is generally classified based on the location in the body that the tumor originates. Most cases are associated with the spleen and/or liver. A smaller percentage of cases are associated with the heart, skin or other locations in the body. What causes hemangiosarcoma? Cancer is caused by a combination of environmental and genetic factors. While certain breeds are predisposed to hemangiosarcoma (German Shepherds, for example), a specific cause is usually not identified. What clinical signs does hemangiosarcoma cause? The signs created by a tumor depend highly on the primary tumor location and stage of the disease. Hemangiosarcoma often causes internal bleeding. This results in anemia (low red cell count) and shock, which can cause acute weakness, collapse, pale gums and tongue, or difficulty breathing. Heart rhythm disturbances created by the disease can also cause similar signs. If left unchecked, these signs may wax and wane. Rarely, abdominal tumors are found incidentally as part of routine examination. Skin tumors may cause no clinical signs or bleeding and bruising under the skin. Finally, animals may die acutely from this disease. Clinical signs may include: Collapse Difficulty breathing Pale gums and tongue Lethargy Palpable masses Seizure Rapid heart rate 3924 Fernandina Road • Columbia, SC 29210 • p: 803-561-0015 • f: 803-561-9874 • www.scvsec.com Canine Hemangiosarcoma What laboratory changes does hemangiosarcoma cause? Most patients with hemangiosarcoma present with a mild to moderate anemia (decreased red blood cell numbers) from internal bleeding.
    [Show full text]
  • Bbm:978-3-642-38765-4/1.Pdf
    Index A Becker nevus and Becker nevus syndrome , Acantholysis, transient superfi cial , 158–159 14, 15, 86, 88–90 Acanthosis nigricans , 19, 20, 141–142, 145, 146 BFH. See Basaloid follicular hamartoma (BFH) Acne nevus of Munro , 91 Binary genodermatoses , 23, 115–118 Acne vulgaris , 26, 200–201, 203 aplasia cutis congenita Acrokeratoelastoidosis , 146 and nevus psiloliparus , 116, 117 AHO. See Albright’s hereditary osteodystrophy (AHO) and nevus sebaceous , 116 Aicardi syndrome , 188–189 nevus sebaceus and melorheostosis , 116 AKT1 mutation , 79, 83, 137 phacomatosis pigmentokeratotica , 115–116 Albinism-deafness syndrome, X-linked , 189–191 phacomatosis pigmentovascularis , 116–118 Albinism, X-linked oculocutaneous , 54 Birt-Hogg-Dubé syndrome. See Hornstein-Knickenberg Albright’s hereditary osteodystrophy (AHO) , 19, 20, syndrome 151–154 Blaschkitis , 49, 195, 205, 208 Allelic didymosis , 23–24, 109–111 Blaschko, Alfred , 9, 45, 47–51 capillary didymosis , 109–111 Blaschko dermatitis , 195 cutis tricolor , 110–111 Blaschko’s lines , 45–59, 63–64, 74 Darier disease , 111, 112 analogous patterns in other organs , 53–58 epidermolytic ichthyosis of Brocq , 111 in animals , 51, 54–56 Amelogenesis imperfecta , 53 atypical lines , 63–64 Anemic halo. See Rhodoid nevus brindle trait , 51, 54, 55 Angiokeratoma circumscriptum , 96 in broad bands , 46, 52–53 Angioma serpiginosum , 96–97 in chimeric mice , 51, 54 Angora hair nevus , 15, 86, 88–89 dwarf zebu, brindle trait , 54, 55 Apert syndrome , 91 embryonic cells , 49, 50 Archetypical patterns , 45–59 in epidermal nevi , 50, 52 Arteriovenous fi stulas , 20, 138, 156 on head and neck , 47, 50 Art nouveau , 57 intraoral lesions , 52 Atopic dermatitis , 26, 194, 195, 197–199 murine brain , 54, 56 ATP7A gene , 188 in narrow bands , 52 ATP2C1 mutation.
    [Show full text]
  • A Vascular Model of Tsc1 Deficiency Accelerates Renal Tumor Formation with Accompanying Hemangiosarcomas
    Published OnlineFirst December 29, 2014; DOI: 10.1158/1541-7786.MCR-14-0178 Oncogenes and Tumor Suppressors Molecular Cancer Research A Vascular Model of Tsc1 Deficiency Accelerates Renal Tumor Formation with Accompanying Hemangiosarcomas Jarrett D. Leech1, Stephen H.T. Lammers1, Sam Goldman1, Neil Auricchio2, Roderick T. Bronson3, David J. Kwiatkowski2, and Mustafa Sahin1 Abstract Tuberous sclerosis complex (TSC) is an autosomal disease sarcomas and kidney cystadenomas were responsive to intra- caused by inactivating mutations in either of the tumor peritoneal rapamycin treatment. Immunoblotting and immu- suppressor genes TSC1 or TSC2. TSC-associated tumor growth nostaining for phospho-S6 (pS6) and phospho-CAD showed is present in multiple tissues and organs including brain, that the effect of rapamycin on tumor size was through kidney, liver, heart, lungs, and skin. In the kidney, TSC inhibition of the mTOR signaling pathway. Finally, elevated angiomyolipomas have aberrant vascular structures with VEGF mRNA levels were also observed in hemangiosarcoma abnormal endothelial cells, suggesting a role for endothelial specimens. Because paw hemangiosarcomas are easily detect- mTORC1 function. In the current report, a genetically engi- able and scorable for size and growth, this novel mouse neered mouse model (GEMM) with a conditional knockout model enables accelerated in vivo drug testing for therapies allele of Tsc1 with a Darpp32-Cre allele displayed accelerated of TSC-related tumors. formation of both kidney cystadenomas and paw hemangio- sarcomas. All mutant mice developed hemangiosarcomas on Implications: These findings provide a strong rationale for simul- multiple paws by 6 weeks of age. By 16 weeks of age, the taneous use of this conditional knockout mouse as an in vivo average mutant hind paw was 4.0 mm in diameter, nearly genetic model while seeking new cancer therapies for TSC-related double the size of control mice.
    [Show full text]